Loading
MetaVia Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Woodworth Marshall H, was filed 04 Jun 2025.
MetaVia Inc.: what insiders have been doing
This page follows insider dealings at MetaVia Inc. as filed with SEC (Form 4), a company from the Health Care sector. Between 21 October 2025 and 21 October 2026, 3 insiders published 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
For context, the typical company on the same exchange (median of 5,454 companies) published 22 filings over the same period, against 3 filings here. Looking back to 2016, when coverage begins, insiders filed 19 purchases and 1 sale. The 10-K for the year ended 31 December 2025 shows -13.0 m USD of net income.
There has been no open-market purchase by an insider of MetaVia Inc. for at least a year. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
89
Thresholds
n/a
Buy Volume
€27M
19 ops. · all time
Sell Volume
€1,378
1 ops. · all time
Who traded when
BuySaleDong-A St Co., Ltd1 buy
Marshall H. Woodworth1 buy
Since the insiders bought
- -66.1%Entry US$7.59 · Close at T+365 US$2.57
- -70.2%Entry US$9.64 · Close at T+365 US$2.87
- -81.9%Entry US$409,200.00 · Close at T+365 US$73,920.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$1.29
Analyst consensus
3 analysts1.50/5
US$8.00Target US$19.33(+1399%)US$30.00
Income statement
EBITDA-US$13.7M
Net income-US$13M0.0% margin
Valuation
P/Book1.2x
Beta0.96
Balance sheet & cash
Market capUS$8.5M
Total debtUS$210k
Free Cash Flow-US$15.7M
Debt / Equity3%
Profitability & ownership
ROE-175.7%
ROA-58.8%
% insiders29.4%
% institutions13.9%
Last declaration on 13 October 2026
Declarations89 total
53,000 shares0Common StockSEC:0001104659-26-115494:0
28,000 shares0Common StockSEC:0001104659-26-006978:0
32,000 shares0Common StockSEC:0001104659-26-006975:0
14,200 shares0Common StockSEC:0001104659-25-077612:0
28,147 shares0Common StockSEC:0001104659-25-064716:0
28,147 shares0Common StockSEC:0001104659-25-064710:0
28,147 shares0Common StockSEC:0001104659-25-064715:0
28,147 shares0Common StockSEC:0001104659-25-064708:0
28,147 shares0Common StockSEC:0001104659-25-064706:0
28,147 shares0Common StockSEC:0001104659-25-064705:0
14,200 shares@ US$0.7064.5% of flowCommon StockSEC:0001104659-25-056382:0
Canonical exit: 2 Sept 2025 (T+90)
4,647,887 shares@ US$0.71100.0% of flowCommon StockSEC:0000899140-25-000718:0
Canonical exit: 6 Aug 2025 (T+90)
2,795 shares@ US$1.4636.2% of flowCommon StockSEC:0001104659-25-020281:0
3,417 shares@ US$1.4635.5% of flowCommon StockSEC:0001104659-25-020282:0
2,867 shares@ US$2.5563.8% of flowCommon StockSEC:0001104659-24-124721:0
407 shares@ US$3.750.0% of flowCommon StockSEC:0000899140-24-001036:0
11,467 shares@ US$3.60100.0% of flowCommon StockSEC:0001104659-24-088925:0
2,544,530 shares@ US$3.9355.7% of flowCommon StockSEC:0000899140-24-000705:0
Canonical exit: 21 Sept 2024 (T+90)
2,544,530 shares@ US$3.1344.3% of flowCommon StockSEC:0000899140-24-000673:0
Canonical exit: 21 Sept 2024 (T+90)
5,051 shares0Common StockSEC:0001104659-24-069785:0
5,051 shares0Common StockSEC:0001104659-24-069788:0
5,051 shares0Common StockSEC:0001104659-24-069786:0
5,051 shares0Common StockSEC:0001104659-24-069784:0
5,051 shares0Common StockSEC:0001104659-24-069783:0
5,051 shares0Common StockSEC:0001104659-24-069787:0
25 of 89 declarations
About MetaVia Inc.
MetaVia Inc. is a company listed on the XNAS market, specializing in the development of innovative technology solutions. It focuses on enhancing user experience through its products and services.
